2026³â 06¿ù 29ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 103611°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



LIG D&A-¶óÀθÞÅ», ÇÕÀÛȸ»ç ¼³¸³ ÃßÁø

À¯·´¡¤NATO ´ÙÃþ ¹æ°ø ü°è ±¸Ãà Çù·Â
LIG µðÆæ½º ¿¡¾î·Î½ºÆäÀ̽º(ÀÌÇÏ LIG D&A)¿Í ¶óÀθÞÅ» ¿¡¾îµðÆæ½º(ÀÌÇÏ ¶óÀθÞÅ»)°¡ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î°í À¯·´ ¹× ³ªÅä(NATO)¿¡ ´ëÇÑ Ã·´Ü ¹æ°ø ½Ã½ºÅÛ °ø±ÞÀ» À§ÇØ Àü¹æÀ§Àû Çù·ÂÀ» ÃßÁøÇÑ´Ù. ¾ç»ç´Â À¯·´ ³» ´ÙÃþ ¹æ°ø ¼ö¿ä°¡ Å©°Ô Áõ°¡ÇÏ´Â »óȲ¿¡¼­ °í°´ ¿ä±¸¿¡ ºÎÇÕÇÏ´Â ÅëÇÕ ¹æ°ø ¼Ö·ç¼ÇÀ» Á¦°øÇϱâ À§ÇÑ Çù·Â ¹æ¾ÈÀ» ³íÀÇÇϰí ÀÖ´Ù. À̸¦ À§ÇÑ Ã¹ Çຸ·Î LIG¿Í ¶óÀθÞÅ» °£ÀÇ À¯·´ ³» ÇÕÀÛȸ»ç ¼³¸³°ú °ü·ÃÇÑ ³íÀǸ¦ ½Éµµ ÀÖ°Ô ÁøÇà ÁßÀÌ´Ù. À̹ø Çù·ÂÀ» ÅëÇØ ¾ç»ç´Â »óÈ£ º¸¿ÏÀûÀÎ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ ±â¹ÝÀ¸·Î À¯·´ ...

¡®ÇÏÆ®½Ã±×³Î5¡¯ ÀÔÁÖÀÚ 8ÀÎ, ÀϺ» µµÄí½Ã¸¶·Î ¿©Çà ¶°³ª

¼³·½°ú ÁúÅõÀÇ ¼Ò¿ëµ¹ÀÌ ¿¹°í
‘ÇÏÆ®½Ã±×³Î5’ ÀÔÁÖÀÚ 8ÀÎÀÌ È¥µ·ÀÇ ·¯ºê¶óÀÎ ¼Ó ÀϺ» µµÄí½Ã¸¶·Î ¿©ÇàÀ» ¶°³­´Ù. 19ÀÏ(È­) ¹ã 10½Ã ¹æ¼ÛµÇ´Â ä³ÎA ‘ÇÏÆ®½Ã±×³Î5’(¿¬Ãâ ¹Úöȯ, ±èÈ«±¸) 6ȸ¿¡¼­´Â ‘½Ã±×³Î ÇϿ콺’ ÀÔÁÖÀÚ 8ÀÎ(¹Ú¿ì¿­-±è¼º¹Î-±è¼­¿ø-Á¤ÁØÇö-±è¹ÎÁÖ-Á¤±Ô¸®-°­À¯°æ-ÃÖ¼ÒÀ±)ÀÌ ÀϺ» µµÄí½Ã¸¶¿¡¼­ ¿©ÇàÀ» °âÇÑ µ¥ÀÌÆ®¸¦ ÇÏ¸ç º¹ÀâÇÑ °¨Á¤ÀÇ ¼Ò¿ëµ¹ÀÌ¿¡ ºüÁö´Â ¸ð½ÀÀÌ ´ã±ä´Ù. À̳¯ ÀϺ»¿¡ µµÂøÇÑ ÀÔÁÖÀÚµéÀº Â÷¸¦ Ÿ°í ¹Ù´å°¡·Î À̵¿ÇÑ´Ù. Â÷ ¾È¿¡¼­ °­À¯°æÀº ¹Ú¿ì¿­ÀÇ ¿·ÀÚ¸®¿¡ ¾É¾Æ ¹à°Ô ¿ô°í, Â÷°¡ Èçµé¸®ÀÚ ¹Ú ...

Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its Firs...

Marks first launch in Japan through partnership with NIPRO CORPORATION.
INCHEON, KOREA -- Samsung Bioepis Co., Ltd. announced the launch of Ustekinumab BS 45 mg Syringe for S.C. Injection ‘NIPRO’, a biosimilar referencing Stelara[1] (ustekinumab), marking its first product launch in Japan under partnership with NIPRO CORPORATION (hereafter “NIPRO”). The launch follows the Official Gazette announcement on May 19 regarding the product’s listing under the National Health Insurance (NHI) Drug Price Standard, which became effective tod ...
MSCI 2023 ESG & Climate Trends to Watch Report Identifies Ne... (2022-12-07)
º¼º¸±×·ìÄÚ¸®¾Æ, â¿ø°øÀå ³» ¹èÅ͸®ÆÑ »ý»ê ½Ã¼³ ¿Ï°ø (2024-05-11)
Ä¡¸Å ¿¹¹æ ÀÎÁöÈÆ·Ã ¾Û ¡®µÎĪ¡¯ ¼­ºñ½º (2023-08-29)
KB±ÝÀ¶±×·ì, ±ÝÀ¶±Ç ÃÖÃÊ °è¿­»ç°£ °í°´¼¾ÅÍ ¿¬°è »ó´ã (2024-05-20)
¿ì¸®±ÝÀ¶¿¡ÇÁ¾Ø¾ÆÀÌ, NPL ÅõÀÚ ½Çź È®º¸ (2024-06-01)
Çö´ëÂ÷±×·ì, E-GMP Ãâ½Ã ÀÌÈÄ Àü±âÂ÷ Åýà 13¹è ±ÞÁõ (2024-06-01)
Çö´ëÂ÷±×·ì Á¦·Î¿ø, 2024 VIVATECH Âü¿© (2024-06-04)
Deel Simplifies Global HR with New Full-Stack Platform (2023-01-30)
ÃÖÁ¾È¸ ¹æ¼Û! MBN ¡®µ¹½Ì±ÛÁî4¡¯ (2023-10-22)
IBK±â¾÷ÀºÇà, ÀͽºÇÇµð¾Æ±×·ì°ú ¿©Çà¼÷¹Ú ÇÒÀÎ ¼­ºñ½º Çù¾à (2024-07-16)
Çѱ¹¼öÀÚ¿ø°ø»ç, Çʸ®ÇÉ ½Åµµ½Ã µî ¹° ¹®Á¦ ÇØ°á (2024-07-22)
Taulia Adds Bank of China and BNP Paribas to Its Funder Netw... (2023-12-06)
Diligent Showcase Launches to Connect Customers with Partner... (2023-05-18)
ReNAgade Therapeutics Launches with over $300 Million in Ser... (2023-05-24)
LGÈ­ÇÐ, µÎ°æºÎ¾Ï ½Å¾à ÀÓ»ó 3»ó µ¹ÀÔ (2024-01-29)
Çö´ë¼º¿ì½ò¶óÀÌÆ®, Çѱ¹´ëÇнºÅ°¿¬¸Í 3³â ¿¬¼Ó ÈÄ¿ø (2024-02-07)
ÈÄÁöÁ¦·Ï½º °í¼º´É DocuMate 4830 ½ºÄ³³Ê (2017-02-10)
KB±¹¹ÎÀºÇà, ¿Ü±¹ÀαٷÎÀÚ Ãâ±¹¸¸±âº¸Çè °øÇ×Áö±Þ¼­ºñ½º (2024-02-28)
º¸À̾Æ, LG G6 ±×¸³ ¹üÆÛ ÄÉÀ̽º Ãâ½Ã (2017-03-27)
ÇÑ»ù, È£ÅÚħ½Ç ±¸ÇöÇÑ ¡®À¯·Î 501¡¯ Ãâ½Ã (2017-04-26)
Eaton Receives Two Grants From the Czech Republic, Continues... (2024-03-14)
±¸¹Ì½Ã, °ü³» »çȸº¹ÁöÁ¾»çÀÚ 1600¿©¸í »óÇØº¸Çè·á Áö¿ø (2024-03-14)
½´Æä¸®¾î°¶·¯¸®, ¹ÚÁö¼÷ ÀÛ°¡ °³ÀÎÀü ¡®Colorful Language¡¯ (2017-05-17)
´ëÇѹα¹ 0.1%¸¸ÀÌ ¾Ë°í ÀÖ´Â ºÎÀÇ ºñ¹Ð, ASPL (2024-03-23)
Å»¸ð, 11°¡Áö ¾àÀ¸·Î Å»ÃâÇÑ´Ù (2016-06-22)
       [ÀÌÀü][1]....[1229][1230][1231][1232][1233][1234][1235][1236][1237]...[4145][´ÙÀ½]

°øÁö»çÇ×
¹Ìµð¾î¿Í M• Mediaour ØÚ体ä² ØÚô÷ä² ¿¥¿À MO ØÚä²
¾Ë¸®¾Ë A⋮⋮⋮ Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
À£ÇÁ·Ò W⋮⋮⋮ Welfrom 卫ÜØ êÛÝ£
¹ÙÀÌ¿ÀÀÌ´Ï B⋮ BIOINI ù±药研 ¹ÙÀÌ¿ÀÀÌ´Ï·¦ BIOINILAB ...
º£³×ÀÍ ¡Õ Beneik 宝Ò¬ìÌ, À̺ñÁî eBizh æ¶币òª EZ æ¶òª
¿¡³ÊÀÌÀ¯ ¡Õ¡Õ EnerEU 额Òö äþÒö
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¾Ë¸®À¯ºñ ^v Alliuv ä¹备 AV ä¹êó备, ¾Ë¶ã =^= Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º ¡ÕC À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò ^ Alfrom ä¹尔ÜØ ä¹ì³ÜØ, ¿ÃÇÁ·Ò A⋮⋮ Allfrom &...
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..